Search
ANI Pharmaceuticals Inc
ANIPAdd to Watchlist
73.590USD
+1.480+2.05%
Close 09-16 16:00（ET）
1.69BMarket Cap
17.89P/E TTM
ANI Pharmaceuticals Inc (ANIP) Revenue Performance
Updated: Jun 30, 2026Last year, ANI Pharmaceuticals Inc generated 384.11M USD for its biggest-performing segment, Sales of generic pharmaceutical products. The United States made the largest contribution, accounting for 852.44M USD last year. For the latest quarter, ANI Pharmaceuticals Inc reported the revenue of 117.13M USD for the period ending 2026-06-30, which came from the top-performing segment, Sales of Cortrophin Gel. United States contributed the highest revenue, at 182.40M USD.
By Business
Revenue
Proportion
Annual
Annual
Quarterly
Sales of generic pharmaceutical products
Sales of rare disease pharmaceutical products
Sales of Cortrophin Gel
Sales of branded pharmaceutical products
Generic pharmaceutical products
Brand
Royalty and other
Sales of contract manufactured products
Royalties from licensing agreements
Product development services
Other
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Sales of generic pharmaceutical products
384.11M(33.22%)
301.00M(43.17%)
269.45M(27.67%)
210.12M(66.41%)
143.57M(66.43%)
147.26M(70.64%)
Sales of rare disease pharmaceutical products
347.78M(30.08%)
198.09M(28.41%)
112.12M(11.52%)
41.69M(13.18%)
--(--)
--(--)
Sales of Cortrophin Gel
347.78M(30.08%)
198.09M(28.41%)
112.12M(11.52%)
--(--)
--(--)
--(--)
Sales of branded pharmaceutical products
76.61M(6.63%)
--(--)
105.25M(10.81%)
39.46M(12.47%)
47.56M(22.01%)
47.96M(23.01%)
Generic pharmaceutical products
--(--)
--(--)
269.45M(27.67%)
--(--)
--(--)
--(--)
Brand
--(--)
--(--)
85.38M(8.77%)
--(--)
--(--)
--(--)
Royalty and other
--(--)
--(--)
19.87M(2.04%)
--(--)
--(--)
--(--)
Sales of contract manufactured products
--(--)
--(--)
--(--)
16.11M(5.09%)
10.04M(4.65%)
9.22M(4.42%)
Royalties from licensing agreements
--(--)
--(--)
--(--)
5.37M(1.70%)
11.79M(5.46%)
1.40M(0.67%)
Product development services
--(--)
--(--)
--(--)
2.95M(0.93%)
1.31M(0.61%)
1.86M(0.89%)
Other
--(--)
--(--)
--(--)
693.00K(0.22%)
1.86M(0.86%)
783.00K(0.38%)
By Region
Revenue
Proportion
Annual
Annual
Quarterly
United States
International
Canada
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
United States
852.44M(96.50%)
604.99M(98.47%)
486.25M(99.88%)
312.43M(98.75%)
211.89M(98.04%)
202.88M(97.32%)
199.66M(96.67%)
196.89M(97.67%)
International
30.92M(3.50%)
9.39M(1.53%)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
Canada
--(--)
--(--)
565.00K(0.12%)
3.96M(1.25%)
4.24M(1.96%)
5.59M(2.68%)
6.88M(3.33%)
4.69M(2.33%)